Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10662/20943
Registro completo de Metadatos
Campo DCValoridioma
dc.contributor.authorDelgado Adámez, Jonathan-
dc.contributor.authorTerrón Sánchez, María del Pilar-
dc.contributor.authorGarcía Martínez, Virginio Enrique-
dc.contributor.authorLópez Sánchez, Carmen-
dc.contributor.authorBarriga Ibars, Carmen-
dc.contributor.authorPariente Llanos, José Antonio-
dc.contributor.authorRodríguez Moratinos, Ana Beatriz-
dc.date.accessioned2024-03-20T13:14:35Z-
dc.date.available2024-03-20T13:14:35Z-
dc.date.issued2011-
dc.identifier.issn1214-021X-
dc.identifier.urihttp://hdl.handle.net/10662/20943-
dc.description.abstractRecent years have seen mounting evidence for the role of melatonin in mediating programmed cell death, with a protective, anti-apoptotic effect in healthy cells, but an anti-tumoural, pro-apoptotic action in many tumour cells. In this study, we evaluated the effect of melatonin on the programmed cell death induced by thapsigargin (TG), on lymphocytes and neutrophils, and on various tissues obtained from rats injected with human promyelocytic leukæmia cells (HL-60), treated with melatonin in their drinking water (20 μm), and fed ad libitum. Melatonin treatment significantly reduced caspase-3 and −9 activity, and caused the proportions of lymphocytes, neutrophils, and eosinophils to revert to their basal values. No histological differences were observed. In conclusion, melatonin has anti-apoptotic effects on lymphocytes and neutrophils obtained from rats injected with HL-60 leukæmia cells.es_ES
dc.description.sponsorshipThis research was supported by MEC-DGI and Junta de Extremadura grants BFU2007-60091 and PRI07-A024, respectively.es_ES
dc.format.extent11 p.es_ES
dc.format.mimetypeapplication/pdfen_US
dc.language.isoenges_ES
dc.publisherUniversity of South Bohemiaes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMelatoninaes_ES
dc.subjectMelatonines_ES
dc.subjectNeutrófiloses_ES
dc.subjectLinfocitoses_ES
dc.subjectApoptosises_ES
dc.subjectCélulas HL-60es_ES
dc.subjectNeutrophilses_ES
dc.subjectLymphocyteses_ES
dc.subjectHL-60 cellses_ES
dc.titleOral melatonin administration and programmed cell death of neutrophils, lymphocytes, and other cell types from rats injected with HL-60 cellses_ES
dc.typearticlees_ES
dc.description.versionpeerReviewedes_ES
europeana.typeTEXTen_US
dc.rights.accessRightsopenAccesses_ES
dc.subject.unesco2401.04 Citología Animales_ES
dc.subject.unesco2302.15 Hormonases_ES
dc.subject.unesco2407.04 Citologíaes_ES
europeana.dataProviderUniversidad de Extremadura. Españaes_ES
dc.identifier.bibliographicCitationDelgado, J., del Pilar Terrón, M., García-Martinez, V., López-Sanchez, C., Barriga, C., Pariente, J.A., & Rodríguez, A.B. (2011). Oral melatonin administration and programmed cell death of neutrophils, lymphocytes, and other cell types from rats injected with HL-60 cells. Journal of Applied Biomedicine, 9(4), 197-207. doi: 10.2478/v10136-011-0006-3es_ES
dc.type.versionpublishedVersiones_ES
dc.contributor.affiliationCICYTEX-La Orden, Área de Producción Animales_ES
dc.contributor.affiliationUniversidad de Extremadura. Departamento de Anatomía, Biología Celular y Zoologíaes_ES
dc.contributor.affiliationUniversidad de Extremadura. Departamento de Fisiologíaes_ES
dc.relation.publisherversionhttps://jab.zsf.jcu.cz/artkey/jab-201104-0003_oral-melatonin-administration-and-programmed-cell-death-of-neutrophils-lymphocytes-and-other-cell-types-from.phpes_ES
dc.identifier.doi10.2478/v10136-011-0006-3-
dc.identifier.publicationtitleJournal of Applied Biomedicinees_ES
dc.identifier.publicationissue4es_ES
dc.identifier.publicationfirstpage197es_ES
dc.identifier.publicationlastpage207es_ES
dc.identifier.publicationvolume9es_ES
dc.identifier.e-issn1214-0287-
dc.identifier.orcid0000-0002-7760-1985es_ES
dc.identifier.orcid0000-0003-3296-2071es_ES
Colección:DABCZ - Artículos
DFSIO - Artículos

Archivos
Archivo Descripción TamañoFormato 
v10136-011-0006-3.pdf3,28 MBAdobe PDFDescargar


Este elemento está sujeto a una licencia Licencia Creative Commons Creative Commons